|Articles|October 1, 2014
- Applied Clinical Trials-10-01-2014
- Volume 23
- Issue 10
Applied Clinical Trials Digital Edition October/November 2014
Trial Design: Identify Blood Pressure Effects Early Demonstrating Biosimilarity CRO/Sponsor: Data Monitoring Committee Users Guide Also in this issue: EU Reshuffling Impacts Pharma "Open Integration" Promise Elusive Assessing Drug-Impaired Driving
Advertisement
Articles in this issue
about 11 years ago
Ebola Research Requires Flexibility by Sponsors, Regulatorsabout 11 years ago
Is 'Open Integration' Beyond Our Reach?about 11 years ago
Cognitive Guidance for Clinical Drug Trialsabout 11 years ago
All Change for Pharma at the European Commissionabout 11 years ago
Europe Unveils Plan to Standardize Clinical Developmentabout 11 years ago
Implementation and Usage of Data Monitoring Committeesabout 11 years ago
Placement of Trials Increasingly Dispersedabout 11 years ago
ACT coverabout 11 years ago
Demonstrating Biosimilarity: PK Considerationsabout 11 years ago
Blood Pressure Evaluation During Early Phase TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
2
Answering the Sustainability Call: Digital Health Technologies and eCOA
3
Addressing Preclinical Gaps to Prevent Biotech Trial Delays
4
KRI Overload: When More Isn’t Better
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
